Open AccessMolecular epidemiology & therapeutic options of carbapenem-resistant Gram-negative bacteria
Author(s) -
Atul Garg,
Jaya Garg,
Sanjay Kumar,
Amitabh Bhattacharya,
Saurabh Agarwal,
G. C. Upadhyay
Publication year - 2019
Publication title -
indian journal of medical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.578
H-Index - 87
ISSN - 0971-5916
DOI - 10.4103/ijmr.ijmr_36_18
Subject(s) - colistin , tigecycline , carbapenem , microbiology and biotechnology , fosfomycin , pseudomonas aeruginosa , acinetobacter baumannii , biology , imipenem , antibiotics , acinetobacter , antibiotic resistance , bacteria , genetics
The growing incidence and the wide diversity of carbapenemase-producing bacterial strains is a major concern as only a few antimicrobial agents are active on carbapenem-resistant bacteria. This study was designed to study molecular epidemiology of carbapenem-resistant Gram-negative bacterial (GNB) isolates from the community and hospital settings.